Primary record
(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-4,8,10,14-tetramethyl-3,11-bis(oxidanyl)-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-hept-5-enoic acid
- 库存
- 4,525 克
- 纯度
- 98.7 %
- CAS
- 6990-06-3
化合物标识与属性
- CAS
- 6990-06-3
- PubChem CID
- 3000226
- SMILES
- C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\C(=O)O)OC(=O)C)C)O)C
- Canonical SMILES
- CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O
名称与同义词
- fusidic acid
- Fusidine
- Ramycin
- Fusidate
- Fucidic acid
- Fucidin acid
- Fucithalmic
- Fucidate
- Taksta
- Acide fusidique
- Acido fusidico
- FUCIDIN
- Flucidin
- Acidum fusidicum
- Fusidate sodium
- Sodium fusidate
- Fucidate Sodium
- 6990-06-3
- Fusidinic Acid
- Diethanolamine fusidate
- Fucidine
- Fuzidin
- fusidic-acid
- Silver Fusidate
- Fusidate Acid
- Fucidin caviject
- Acid, Fusidic
- Fucidin Cream 2%
- Fusidate, Silver
- 1qca
- Anhydrous Fusidic Acid
- (-)-Fusidic acid
- Fusidic acid CRS
- Fucithalmic (TN)
- Fucicort (TN)
- Fucidine (TN)
- Fusiderm (TN)
- Fusidic acid sodium
- Fucibet (TN)
- Fucidin (TN)
- Fucizon (TN)
- Fusidin (TN)
- FUSIDICACID
- Fudic (TN)
- Fusid (TN)
- Fuci (TN)
- RefChem:5848
- Fusidic acid (Standard)
- Fusidic acid (USAN/INN)
- CEM-102
- Prestwick2_000390
- D0X7XG
- FUSIDIC ACID [MI]
- AC1MHD21
- FUSIDIC ACID [INN]
- MLS001332649
- 59XE10C19C
- FUSIDIC ACID [USAN]
- MFCD00865135
- NSC-56192
- SCHEMBL25646
- DTXSID0023086
- CHEBI:29013
- MLS001332650
- MLS002207094
- UNII-59XE10C19C
- Acide fusidique [INN-French]
- Acido fusidico [INN-Spanish]
- Acidum fusidicum [INN-Latin]
- FUSIDIC ACID [WHO-DD]
- IECPWNUMDGFDKC-MZJAQBGESA-N
- CEM102
- CHEMBL374975
- DTXCID103086
- orb1309560
- orb3025513
- SQ 16,603
- ZN 6
- ZN-6
- FUSIDIC ACID SODIUM SALT
- Fusidic acid [USAN:INN:BAN]
- SQ-16603
- BDBM58924
- cid_3000226
- ERK5-1F17
- GTPL10815
- HY-B1350R
- AOB5628
- D06AX01
- J01XC01
- S01AA13
- GLXC-06549
- HMS2235B11
- SQ 16603
- FUSIDIC ACID [EP IMPURITY]
- ACT03304
- C31H48O6
- EX-A3797
- FUSIDIC ACID [EP MONOGRAPH]
- HY-B1350
- NSC56192
- ZINC8143796
- EINECS 230-256-0
- Fusidic acid for peak identification
- Fusidic acid, 98.5% - 1g 1g
- BBF-01862
- C.A.S. 62
- EBC-27263
- MSK157136
- NSC 56192
- s3971
- SMR000857101
- AKOS005146257
- ACN-048187
- AF23629
- C.A.S. 62,602
- CCG-269829
- CID3000226
- CS-O-01526
- DB02703
- DS-3261
- LMPR0106040001
- Fusidic acid for peak identification CRS
- NCGC00485232-01
- J16.166G
- SY056012
- (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
- C.A.S. 62,602; Diethanolamine fusidate
- 2178A
- CS-0013095
- F1007
- FT-0630359
- NS00007426
- A-8646
- C06694
- D04281
- 150400-EP2289892A1
- 990F063
- A900014
- EN300-22411576
- Q259930
- (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid
- (2E)-2-[(3R,4S,5S,8S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
- (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-hept-5-enoic acid
- 16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid
- Fusidic acid, European Pharmacopoeia (EP) Reference Standard
- (-)-16beta-acetoxy-3alpha,11alpha-dihydroxyfusida-17(20)Z,24-diene-21-oic acid
- (2Z)-2-[(17Z)-16beta-acetoxy-3alpha,11alpha-dihydroxy-4alpha,8alpha,10,14beta-tetramethyl-5alpha,9beta,13alpha-gonan-17-ylidene]-6-methylhept-5-enoic acid
- (2Z)-2-[(3alpha,4alpha,5alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-16-(acetyloxy)-3,11-dihydroxy-4,8,10,14-tetramethylgonan-17-ylidene]-6-methylhept-5-enoic acid
- (Z)-2-((3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyldodecahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-6-methylhept-5-enoic acid
- 2-[(1Z,2S,3aS,3bS,5aS,6S,7R,9aS,9bS,10R,11aR)-2-(acetyloxy)-7,10-dihydroxy-3a,3b,6,9a-tetramethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoic acid
- 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-
- 3alpha,11alpha,16beta-Trihydroxy-29-nor-8alpha,9beta,13alpha,14beta-dammara-17(20),24-dien-21-oic acid 16-acetate
- (17Z)-3alpha,11alpha-Dihydroxy-16beta-acetoxy-5alpha-fusida-17(20),24-dien-21-oic acid
- Fusidic acid for peak identification, European Pharmacopoeia (EP) Reference Standard
- (17Z)-16beta-(Acetyloxy)-3alpha,11alpha-dihydroxy-4alpha,8,14-trimethyl-5alpha,8alpha,9beta,13alpha,14beta-18-norcholesta-17,24-dien-21-oic acid
- (17Z)-3alpha,11alpha-Dihydroxy-16beta-acetoxy-5alpha-fusidane-17(20),24-diene-21-oic acid
- (2Z)-2-((3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta(a)phenanthren-17-ylidene)-6-methylhept-5-enoic acid
- (2Z)-2-[(3beta,4beta,5alpha,8alpha,9beta,11beta,13alpha,16beta,17Z)-16-(acetyloxy)-3,11-dihydroxy-4,8,10,14-tetramethylgonan-17-ylidene]-6-methylhept-5-enoic acid
- (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-5-heptenoic acid
- (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-4,8,10,14-tetramethyl-3,11-bis(oxidanyl)-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-hept-5-enoic acid
- (3|A,4|A,8|A,9|A,11|A,13|A,14|A,16|A,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid
- (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,147beta,167beta,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic Acid
- (4alpha,8alpha,9beta,13alpha,14beta,17Z)-16beta-(Acetyloxy)-3alpha,11alpha-dihydroxy-29-nor-5alpha-dammara-17(20),24-dien-21-oic acid
- (4S,8alpha,9beta,13alpha,14beta,17Z)-16beta-Acetoxy-3alpha,11alpha-dihydroxy-29-nor-5alpha-dammara-17(20),24-dien-21-oic acid
- (8alpha,9beta,13alpha,14beta,Z)-16beta-Acetyloxy-3alpha,11alpha-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid
- 230-256-0
- 29-Nor-8.alpha.,13.alpha.,14.beta.-dammara-17(20),24-dien-21-oic acid, 3.alpha.,11.alpha.,16.beta.-trihydroxy-, 16-acetate, (Z)-
- 29-Nor-8alpha,9beta,13alpha,14beta-dammara-17(20),24-dien-21-oic acid, 3alpha,11alpha,16beta-trihydroxy-, 16-acetate, (Z)-
- 29-Nordammara-17(20), 16-(acetyloxy)-3,11-dihydroxy-, (3.alpha.,4.alpha.,8.alpha.,9.beta.,11.alpha.,13.alpha.,14.beta.,16.beta.,17Z)-
- 29-NORDAMMARA-17(20),24-DIEN-21-OIC ACID, 16-(ACETYLOXY)-3,11-DIHYDROXY-, (3.ALPHA.,4.ALPHA.,8.ALPHA.,9.BETA.,11.ALPHA.,13.ALPHA.,14.BETA.,16.BETA.,17Z)
- 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3a,4a,8a,9b,11a,13a,14b,16b,17Z)-
- 3.alpha.,11.alpha.,16.beta.-Trihydroxy-29-nor-8.alpha.,9.beta.,13.alpha.,14.beta.-dammara-17(20),24-dien-21-oic acid 16-acetate
- 3.alpha.,16.beta.-Trihydroxy-29-nor-8.alpha.,9.beta.,13.alpha.,14.beta.-dammara-17(20),24-dien-21-oic acid 16-acetate
- FUA
- Fusidic Acid; Fusidine; 6990-06-3; Ramycin; Fucithalmic; Fucidic Acid; Fucidin Acid; FUCIDIN;
- na